Have a personal or library account? Click to login
Update on the Non-Huntington’s Disease Choreas with Comments on the Current Nomenclature Cover

Update on the Non-Huntington’s Disease Choreas with Comments on the Current Nomenclature

By: Ruth H. Walker  
Open Access
|Jan 2012

References

  1. 1
    WalkerRHDifferential diagnosis of chorea.Curr Neurol Neurosci Rep20111138539510.1007/s11910-011-0202-221465146
  2. 2
    WalkerRHThe differential diagnosis of chorea. 2011.Oxford University PressNew YorkNY
  3. 3
    Huntington Study GroupA novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.Cell19937297198310.1016/0092-8674(93)90585-E8458085
  4. 4
    AndrewSEGoldbergYPKremerBet alHuntington disease without cag expansion - phenocopies or errors in assignment.Am J Hum Genet1994548528638178825
  5. 5
    StevaninGFujigasakiHLebreASet alHuntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes.Brain20031261599160310.1093/brain/awg15512805114
  6. 6
    VuillaumeIMeynieuPSchraen-MaschkeSet alAbsence of unidentified CAG repeat expansion in patients with Huntington's disease-like phenotype.J Neurol Neurosurg Psychiatry20006867267510.1136/jnnp.68.5.67210766906
  7. 7
    XiangFAlmqvistEWHuqMet alA Huntington disease-like neurodegenerative disorder maps to chromosome 20p.Am J Hum Genet199863143114389792871
  8. 8
    MooreRCXiangFMonaghanJet alHuntington disease phenocopy is a familial prion disease.Am J Hum Genet2001691385138811593450
  9. 9
    LaplancheJLHachimiKHDurieuxIet alProminent psychiatric features and early onset in an inherited prion disease with a new insertional mutation in the prion protein gene.Brain19991222375238610.1093/brain/122.12.237510581230
  10. 10
    MargolisRLO'HearnERosenblattAet alA disorder similar to Huntington's disease is associated with a novel CAG repeat expansion.Ann Neurol200150373380
  11. 11
    HolmesSEO'HearnERosenblattAet alA repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2.Nat Genet20012937737810.1038/ng76011694876
  12. 12
    WilburnBRudnickiDDZhaoJet alAn antisense CAG repeat transcript at JPH3 locus mediates expanded polyglutamine protein toxicity in Huntington's disease-like 2 mice.Neuron20117042744010.1016/j.neuron.2011.03.02121555070
  13. 13
    RudnickiDDHolmesSELinMWet alHuntington's disease-like 2 is associated with CUG repeat-containing RNA foci.Ann Neurol20076127228210.1002/ana.2108117387722
  14. 14
    RodriguesGGWalkerRHBriceAet alHuntington's disease-like 2 in Brazil—Report of 4 patients.Mov Disord2008232244224710.1002/mds.2222318816802
  15. 15
    SantosCWanderleyHVedolinLet alHuntington disease-like 2: the first patient with apparent European ancestry.Clin Genet20087348048510.1111/j.1399-0004.2008.00981.x18341606
  16. 16
    MagaziDSKrauseABonevVet alHuntington's disease: genetic heterogeneity in black African patients.S Afr Med J20089820020318350222
  17. 17
    WalkerRHRasmussenARudnickiDet alHuntington's Disease-like 2 can present as chorea-acanthocytosis.Neurology2003611002100414557581
  18. 18
    KambourisMBohlegaSAl TahanAet alLocalization of the gene for a novel autosomal recessive neurodegenerative Huntington-like disorder to 4p15.3.Am J Hum Genet20006644545210677304
  19. 19
    RichfieldEKVonsattelJPMacdonaldMEet alSelective loss of striatal preprotachykinin neurons in a phenocopy of Huntington's disease.Mov Disord20021732733210.1002/mds.1003211921119
  20. 20
    SchneiderSAvan de WarrenburgBPHughesTDet alPhenotypic homogeneity of the Huntington disease-like presentation in a SCA17 family.Neurology2006671701170310.1212/01.wnl.0000242740.01273.0017101913
  21. 21
    NamekawaMTakiyamaYAndoYet alChoreiform movements in spinocerebellar ataxia type 1.J Neurol Sci200118710310610.1016/S0022-510X(01)00527-511440752
  22. 22
    GeschwindDHPerlmanSFigueroaCPet alThe prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia.Am J Hum Genet1997608428509106530
  23. 23
    RottnekMRiggioSByneWet alSchizophrenia in a patient with spinocerebellar ataxia 2: coincidence of two disorders or a neurodegenerative disease presenting with psychosis?Am J Psychiatry200816596496718676601
  24. 24
    Le BerICamuzatACastelnovoGet alPrevalence of dentatorubral-pallidoluysian atrophy in a large series of white patients with cerebellar ataxia.Arch Neurol2003601097109910.1001/archneur.60.8.109712925365
  25. 25
    WardleMMajounieEWilliamsNMet alDentatorubral pallidoluysian atrophy in South Wales.J Neurol Neurosurg Psychiatry20087980480710.1136/jnnp.2007.12807417965145
  26. 26
    BurkeJRWingfieldMSLewisKEet alThe Haw River Syndrome: Dentatorubropallidoluysian atrophy (DRPLA) in an African-American family.Nat Genet1994752152410.1038/ng0894-5217951323
  27. 27
    LevineIMEstesJWLooneyJMHereditary neurological disease with acanthocytosis. A new syndrome.Arch Neurol19681940340910.1001/archneur.1968.004800400690075677189
  28. 28
    CritchleyEMClarkDBWiklerAAcanthocytosis and neurological disorder without betalipoproteinemia.Arch Neurol19681813414010.1001/archneur.1968.004703200360045636069
  29. 29
    HiroseHNeuroacanthocytosis in Japan—Review of the literature and cases.Neuroacanthocytosis Syndromes IIWalkerRHSaikiSDanekASpringer-VerlagBerlin Heidelberg20087584
  30. 30
    HardieRJPullonHWHardingAEet alNeuroacanthocytosis. A clinical, haematological and pathological study of 19 cases.Brain199111413491998879
  31. 31
    GandhiSHardieRJLeesAJAn update on the Hardie neuroacanthocytosis series.Neuroacanthocytosis Syndromes IIWalkerRHSaikiSDanekASpringer-VerlagBerlin HeidelbergGermany20084351
  32. 32
    Velayos-BaezaAHolinski-FederENietzelBet alChorea-acanthocytosis genotype in Critchley's original Kentucky neuroacanthocytosis kindred.Arch Neurol2011681330133310.1001/archneurol.2011.23921987550
  33. 33
    UenoSMarukiYNakamuraMet alThe gene encoding a newly discovered protein, chorein, is mutated in chorea-acanthocytosis.Nat Genet20012812112210.1038/8882511381254
  34. 34
    RampoldiLDobson-StoneCRubioJPet alA conserved sorting-associated protein is mutant in chorea-acanthocytosis.Nat Genet20012811912010.1038/8882111381253
  35. 35
    Velayos-BaezaAVettoriACopleyRRet alAnalysis of the human VPS13 gene family.Genomics20048453654910.1016/j.ygeno.2004.04.01215498460
  36. 36
    RampoldiLDanekAMonacoAPClinical features and molecular bases of neuroacanthocytosis.J Mol Med20028047549112185448
  37. 37
    Dobson-StoneCVelayos-BaezaAFilipponeLAet alChorein detection for the diagnosis of chorea-acanthocytosis.Ann Neurol20045629930210.1002/ana.2020015293285
  38. 38
    Dobson-StoneCDanekARampoldiLet alMutational spectrum of the CHAC gene in patients with chorea-acanthocytosis.Eur J Hum Genet20021077378112404112
  39. 39
    SorrentinoGDe RenzoAMinielloSet alLate appearance of acanthocytes during the course of chorea-acanthocytosis.J Neurol Sci199916317517810.1016/S0022-510X(99)00005-210371080
  40. 40
    BayreutherCBorgMChorea-acanthocytosis: a diagnosis not to be ruled out in absence of acanthocytes.J Neurol200825598
  41. 41
    MalandriniAFabriziGMPalmeriSet alChoreo-acanthocytosis like phenotype without acanthocytes: clinicopathological case report. A contribution to the knowledge of the functional pathology of the caudate nucleus.Acta Neuropathol (Berl)19938665165810.1007/BF002943068310821
  42. 42
    SymmansWAShepherdCSMarshWLet alHereditary acanthocytosis associated with the McLeod phenotype of the Kell blood group system.Br J Haematol197942575583476009
  43. 43
    RedmanCMRussoDLeeSKell, Kx and the McLeod syndrome.Baillieres Best Pract Res Clin Haematol19991262163510.1053/beha.1999.004510895256
  44. 44
    DanekARubioJPRampoldiLet alMcLeod neuroacanthocytosis: genotype and phenotype.Ann Neurol20015075576410.1002/ana.1003511761473
  45. 45
    JungHHHergersbergMKneifelSet alMcLeod syndrome: a novel mutation, predominant psychiatric manifestations, and distinct striatal imaging findings.Ann Neurol20014938439210.1002/ana.7611261514
  46. 46
    DanekATisonFRubioJet alThe chorea of McLeod syndrome.Mov Disord20011688288910.1002/mds.118811746618
  47. 47
    WalkerRHDanekAUttnerIet alMcLeod phenotype without the McLeod syndrome.Transfusion20064729930510.1111/j.1537-2995.2007.01106.x17302777
  48. 48
    OechslinEKaupDJenniRet alCardiac abnormalities in McLeod syndrome.Int J Cardiol200913213013218045706
  49. 49
    HayflickSJWestawaySKLevinsonBet alGenetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome.N Engl J Med2003348334012510040
  50. 50
    OrrellRWAmroliaPJHealdAet alAcanthocytosis, retinitis pigmentosa, and pallidal degeneration: a report of three patients, including the second reported case with hypoprebetalipoproteinemia (HARP syndrome).Neurology1995454874927898702
  51. 51
    ZhouBWestawaySKLevinsonBet alA novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome.Nat Genet20012834534910.1038/ng57211479594
  52. 52
    ShevellMIPeifferJJulius Hallervorden's wartime activities: implications for science under dictatorship.Pediatr Neurol20012516216510.1016/S0887-8994(00)00243-511551747
  53. 53
    ShevellMHallervorden and history.N Engl J Med20033483412510036
  54. 54
    MalandriniACesarettiSMulinariMet alAcanthocytosis, retinitis pigmentosa, pallidal degeneration. Report of two cases without serum lipid abnormalities.J Neurol Sci199614012913110.1016/0022-510X(96)00155-48866438
  55. 55
    CurtisARFeyCMorrisCMet alMutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease.Nat Genet20012835035410.1038/ng57111438811
  56. 56
    CromptonDEChinneryPFBatesDet alSpectrum of movement disorders in neuroferritinopathy.Mov Disord200420959910.1002/mds.2028415390132
  57. 57
    MirPEdwardsMJCurtisARet alAdult-onset generalized dystonia due to a mutation in the neuroferritinopathy gene.Mov Disord20042024324510.1002/mds.2028015390032
  58. 58
    KubotaAHidaAIchikawaYet alA novel ferritin light chain gene mutation in a Japanese family with neuroferritinopathy: description of clinical features and implications for genotype-phenotype correlations.Mov Disord20092444144510.1002/mds.2243519117339
  59. 59
    XuXPinSGathinjiMet alAceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis.Ann N Y Acad Sci2004101229930510.1196/annals.1306.02415105274
  60. 60
    MiyajimaHAceruloplasminemia, an iron metabolic disorder.Neuropathology20032334535010.1046/j.1440-1789.2003.00521.x14719552
  61. 61
    McNeillAPandolfoMKuhnJet alThe neurological presentation of ceruloplasmin gene mutations.Eur Neurol20086020020510.1159/00014869118667828
  62. 62
    McNeillABirchallDHayflickSJet alT2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation.Neurology2008701614161910.1212/01.wnl.0000310985.40011.d618443312
  63. 63
    MorganNVWestawaySKMortonJEet alPLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron.Nat Genet20063875275410.1038/ng182616783378
  64. 64
    GregoryAWestawaySKHolmIEet alNeurodegeneration associated with genetic defects in phospholipase A(2).Neurology2008711402140910.1212/01.wnl.0000327094.67726.2818799783
  65. 65
    MubaidinARobertsEHampshireDet alKarak syndrome: a novel degenerative disorder of the basal ganglia and cerebellum.J Med Genet20034054354610.1136/jmg.40.7.54312843330
  66. 66
    SchneiderSAPaisan-RuizCQuinnNPet alATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation.Mov Disord20102597998410.1002/mds.2294720310007
  67. 67
    KruerMCPaisan-RuizCBoddaertNet alDefective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA).Ann Neurol20106861161810.1002/ana.2212220853438
  68. 68
    BreedveldGJvan DongenJWDanesinoCet alMutations in TITF-1 are associated with benign hereditary chorea.Hum Mol Genet20021197197910.1093/hmg/11.8.97111971878
  69. 69
    MahajnahMInbarDSteinmetzAet alBenign hereditary chorea: clinical, neuroimaging, and genetic findings.J Child Neurol2007221231123410.1177/088307380730626117940252
  70. 70
    DevosDVuillaumeIDe BecdelievreAet alNew syndromic form of benign hereditary chorea is associated with a deletion of TITF-1 and PAX-9 contiguous genes.Mov Disord2006212237224010.1002/mds.2113517044090
  71. 71
    BauerPKreuzFRBurkKet alMutations in TITF1 are not relevant to sporadic and familial chorea of unknown cause.Mov Disord2006211734173710.1002/mds.2103116830318
  72. 72
    SchragAQuinnNPBhatiaKPet alBenign hereditary chorea—Entity or syndrome?Mov Disord20001528028810.1002/1531-8257(200003)15:2<;280::AID-MDS1011>3.0.CO;2-Q10752577
  73. 73
    AsmusFHorberVPohlenzJet alA novel TITF-1 mutation causes benign hereditary chorea with response to levodopa.Neurology2005641952195410.1212/01.WNL.0000164000.75046.CC15955952
  74. 74
    Kleiner-FismanGCalingasanNYPuttMet alAlterations of striatal neurons in benign hereditary chorea.Mov Disord2005201353135710.1002/mds.2057715986422
  75. 75
    MaccabelliGPichiecchioAGualaAet alAdvanced magnetic resonance imaging in benign hereditary chorea: study of two familial cases.Mov Disord2010252670267410.1002/mds.2328120803509
  76. 76
    SalvatoreEDi MaioLFillaAet alBenign hereditary chorea: clinical and neuroimaging features in an Italian family.Mov Disord2010251491149610.1002/mds.2306520544814
  77. 77
    KrudeHSchutzBBiebermannHet alChoreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency.J Clin Invest200210947548011854319
  78. 78
    FerraraAMDe MicheleGSalvatoreEet alA novel NKX2.1 mutation in a family with hypothyroidism and benign hereditary chorea.Thyroid2008181005100910.1089/thy.2008.008518788921
  79. 79
    WillemsenMABreedveldGJWoudaSet alBrain-thyroid-lung syndrome: a patient with a severe multi-system disorder due to a de novo mutation in the thyroid transcription factor 1 gene.Eur J Pediatr2005164283015517377
  80. 80
    KujawaKANiemiVRTomasiMAet alBallistic-choreic movements as the presenting feature of renal cancer.Arch Neurol2001581133113510.1001/archneur.58.7.113311448303
  81. 81
    TaniTPiaoYMoriSet alChorea resulting from paraneoplastic striatal encephalitis.J Neurol Neurosurg Psychiatry20006951251510.1136/jnnp.69.4.51210990513
  82. 82
    BatchelorTTPlattenMPalmer-ToyDEet alChorea as a paraneoplastic complication of Hodgkin's disease.J Neurooncol19983618519010.1023/A:10058601031739525818
  83. 83
    VerninoSTuitePAdlerCHet alParaneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma.Ann Neurol20025162563010.1002/ana.1017812112110
  84. 84
    DorbanSGilleMKesslerRet al[Chorea-athetosis in the anti-Hu syndrome].Rev Neurol (Paris)200416012612910.1016/S0035-3787(04)70863-214978409
  85. 85
    HonnoratJCartalat-CarelSRicardDet alOnco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies.J Neurol Neurosurg Psychiatry20098041241610.1136/jnnp.2007.13801618931014
  86. 86
    Krolak-SalmonPAndrodiasGMeyronetDet alSlow evolution of cerebellar degeneration and chorea in a man with anti-Yo antibodies.Eur J Neurol20061330730816618353
  87. 87
    LucaNDaengsuwanTDalmauJet alAnti-N-methyl-D-aspartate receptor encephalitis: A newly recognized inflammatory brain disease in children.Arthritis Rheum2011632515252210.1002/art.30437
  88. 88
    DalmauJLancasterEMartinez-HernandezEet alClinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.Lancet Neurol201110637410.1016/S1474-4422(10)70253-221163445
  89. 89
    HughesEGPengXGleichmanAJet alCellular and synaptic mechanisms of anti-NMDA receptor encephalitis.J Neurosci2010305866587510.1523/JNEUROSCI.0167-10.201020427647
  90. 90
    VincentABienCGAnti-NMDA-receptor encephalitis: a cause of psychiatric, seizure, and movement disorders in young adults.Lancet Neurol200871074107510.1016/S1474-4422(08)70225-418851929
  91. 91
    DalmauJTuzunEWuHYet alParaneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.Ann Neurol200761253610.1002/ana.2105017262855
  92. 92
    LahiriNMeadSTabriziSJChorea in the prion diseases.The differential diagnosis of choreaWalkerRHOxford University PressNew York2011188205
  93. 93
    BowenJMitchellTPearceRet alChorea in new variant Creutzfeldt-Jacob disease.Mov Disord2000151284128510.1002/1531-8257(200011)15:6<;1284::AID-MDS1043>3.0.CO;2-Y11104228
  94. 94
    McKeeDTalbotPChorea as a presenting feature of variant Creutzfeldt-Jakob disease.Mov Disord20031883783810.1002/mds.1042312815669
  95. 95
    YianniJNandiDBradleyKet alSenile chorea treated by deep brain stimulation: a clinical, neurophysiological and functional imaging study.Mov Disord20041959760210.1002/mds.1071615133831
  96. 96
    BurbaudPRougierAFerrerXet alImprovement of severe trunk spasms by bilateral high-frequency stimulation of the motor thalamus in a patient with chorea-acanthocytosis.Mov Disord20021720420710.1002/mds.126011835468
  97. 97
    WihlGVolkmannJAllertNet alDeep brain stimulation of the internal pallidum did not improve chorea in a patient with neuro-acanthocytosis.Mov Disord20011657257510.1002/mds.110911391763
  98. 98
    RuizPJAyerbeJBaderBet alDeep brain stimulation in chorea acanthocytosis.Mov Disord2009241546154710.1002/mds.2259219425062
  99. 99
    BurbaudPDeep brain stimulation in neuroacanthocytosis.Mov Disord20052016811682
  100. 100
    WataraiMHashimotoTYamamotoKet alPallidotomy for severe generalized chorea of juvenile-onset dentatorubral-pallidoluysian atrophy.Neurology2003611452145414638982
  101. 101
    FujimotoYIsozakiEYokochiFet al[A case of chorea-acanthocytosis successfully treated with posteroventral pallidotomy].Rinsho Shinkeigaku1997378918949490899
  102. 102
    JankovicJOrmanJTetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.Neurology1988383913943279337
  103. 103
    ChatterjeeAFruchtSJTetrabenazine in the treatment of severe pediatric chorea.Mov Disord20031870370610.1002/mds.1042712784277
  104. 104
    PearsonSJReynoldsGPDepletion of monoamine transmitters by tetrabenazine in brain tissue in Huntington's disease.Neuropharmacology19882771771910.1016/0028-3908(88)90080-92901681
  105. 105
    MossJHStewartDEIatrogenic parkinsonism in Huntington's chorea.Can J Psychiatry1986318658662948633
  106. 106
    LinFCWeiLJShihPYEffect of levetiracetam on truncal tic in neuroacanthocytosis.Acta Neurol Taiwan200615384216599284
  107. 107
    Al-AsmiAJansenACBadhwarAet alFamilial temporal lobe epilepsy as a presenting feature of choreoacanthocytosis.Epilepsia2005461256126310.1111/j.1528-1167.2005.65804.x16060937
  108. 108
    LucettiCDel DottoPGambacciniGet alIV amantadine improves chorea in Huntington's disease: an acute randomized, controlled study.Neurology2003601995199712821751
  109. 109
    VerhagenMLMorrisMJFarmerCet alHuntington's disease: a randomized, controlled trial using the NMDA-antagonist amantadine.Neurology20025969469912221159
  110. 110
    O'suilleabhainPDeweyRBJrA randomized trial of amantadine in Huntington disease.Arch Neurol20036099699810.1001/archneur.60.7.99612873857
  111. 111
    RosasHDKoroshetzWJJenkinsBGet alRiluzole therapy in Huntington's disease (HD).Mov Disord19991432633010.1002/1531-8257(199903)14:2<;326::AID-MDS1019>3.0.CO;2-Q10091628
  112. 112
    SeppiKMuellerJBodnerTet alRiluzole in Huntington's disease (HD): an open label study with one year follow up.J Neurol200124886686911697523
  113. 113
    HenkelKDanekAGrafmanJet alHead of the caudate nucleus is most vulnerable in chorea-acanthocytosis: a voxel-based morphometry study.Mov Disord2006211728173110.1002/mds.2104616874760
  114. 114
    HuppertzHJKroll-SegerJDanekAet alAutomatic striatal volumetry allows for identification of patients with chorea-acanthocytosis at single subject level.J Neural Transm20081151393140010.1007/s00702-008-0094-818648728
  115. 115
    WalterfangMLooiJCStynerMet alShape alterations in the striatum in chorea-acanthocytosis.Psychiatry Res2011192293610.1016/j.pscychresns.2010.10.00621377843
  116. 116
    ValkoPOHanggiJMeyerMet alEvolution of striatal degeneration in McLeod syndrome.Eur J Neurol20101761261819968700
  117. 117
    IsmailogullariSCaglayanAOBaderBet alMagnetic resonance spectroscopy in two siblings with chorea-acanthocytosis.Mov Disord2010252894289710.1002/mds.2336520842686
DOI: https://doi.org/10.5334/tohm.122 | Journal eISSN: 2160-8288
Language: English
Submitted on: Jun 29, 2011
Accepted on: Aug 8, 2011
Published on: Jan 30, 2012
Published by: Columbia University Libraries/Information Services
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2012 Ruth H. Walker, published by Columbia University Libraries/Information Services
This work is licensed under the Creative Commons License.